CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,648,066
- in 4 filings, $436K under 10b5-1 plans
Net −$1,648,066. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-10-07 | Kelbon Marcia S. VP Patent and General Counsel | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2012-10-07 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2012-09-26 | Cable Thomas J. Director | Sale | −5,000 | $9.60 | $48K | 92,067 |
| 2012-09-26 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2012-09-07 | Cable Thomas J. Director | Gift | −2,000 | 97,067 | ||
| 2012-06-27 | Demopulos Peter A MD Director | Purchase | +14,635 | $10.25 | $150K | 165,722 |
| 2012-06-01 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-06-01 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-06-01 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-06-01 | Aspiri Ray Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-06-01 | SPIEGELMAN DANIEL K Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2012-03-12 | Demopulos Peter A MD Director | Exercise or conversion | +6,666 | $7.56 | $50K | 146,087 |
| 2012-03-12 | Demopulos Peter A MD Director | Exercise or conversion | +5,000 | $5.92 | $30K | 151,087 |
| 2012-03-12 | Demopulos Peter A MD Director | Exercise or conversion · Stock Option (Right to Buy) | −6,666 | 3,334 | ||
| 2012-03-12 | Demopulos Peter A MD Director | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2012-01-08 | Kelbon Marcia S. VP Patent and General Counsel | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2012-01-08 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (Right to Buy) | +260,000 | 260,000 | ||
| 2011-08-22 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion | +10,000 | $0.98 | $10K | 1,236,822 |
| 2011-08-22 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 398,163 | ||
| 2011-08-18 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion | +1,542 | $0.52 | $802 | 1,226,822 |
Page 23 of 27 · 522 trades